TITLE | STATUS |
WO04112687
Antiviral compounds and methods Priority – 26 June 2003 |
Granted in Australia, Brazil, Canada, China, France, Germany, India, Japan, Korea, New Zealand, Singapore, South Africa, United Kingdom and USA
Under examination elsewhere (Hong Kong) |
WO06135978
Antiviral compounds and methods Priority – 24 June 2005 |
Granted in Austria, Australia, Belgium, Brazil, Canada, China, Denmark, Germany, Finland, France, Hong Kong, Ireland, Italy, Japan, Korea, Luxembourg, Monaco, The Netherlands, New Zealand, Poland, Portugal, Singapore, South Africa, Spain, Sweden, Switzerland, Turkey, United Kingdom and USA
Under examination elsewhere (India) |
WO2009/018609
Hepatitis C antiviral compounds and methods Priority – 3 August 2007 |
Granted in Austria, Australia, Belgium, Brazil, Canada, China, Denmark, Finland, France, Germany, Hong Kong, Ireland, Italy, Japan, Korea, Luxembourg, Monaco, The Netherlands, New Zealand, Poland, Portugal, Singapore, South Africa, Spain, Sweden, Switzerland, Turkey and United Kingdom
Under examination in elsewhere (India) |
WO/2018/145148
Methods of Treating Influenza Priority – 8 February 2017 |
Granted in Belgium, China, France, Germany, Ireland, Italy, Japan, Mexico, The Netherlands, Russia, Singapore, South Africa, Spain, Switzerland, United Kingdom and USA
Under examination in Australia, Brazil, Canada, El Salvador, Hong Kong, Korea, New Zealand and Thailand |
PCT/AU2020/51273
Methods of Treating HIV-1 Infection Priority – 26 November 2019 |
Under examination in Canada, China, Israel, Singapore and South Africa
Applications filed in Australia, Brazil, Europe, Japan, Korea, Malaysia, Mexico, New Zealand, Russia, Thailand and USA |
WO2023092180
Methods of Treating SARS-CoV-2 Priority – 24 November 2021 |
PCT filed |
Table updated October 2023